Cargando…
Year-in-Review of Lung Cancer
In the last several years, we have made slow but steady progress in understanding molecular biology of lung cancer. This review is focused on advances in understanding the biology of lung cancer that have led to proof of concept studies on new therapeutic approaches. The three selected topics includ...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Tuberculosis and Respiratory Diseases
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3492398/ https://www.ncbi.nlm.nih.gov/pubmed/23166546 http://dx.doi.org/10.4046/trd.2012.73.3.137 |
_version_ | 1782249126953484288 |
---|---|
author | Son, Ji Woong |
author_facet | Son, Ji Woong |
author_sort | Son, Ji Woong |
collection | PubMed |
description | In the last several years, we have made slow but steady progress in understanding molecular biology of lung cancer. This review is focused on advances in understanding the biology of lung cancer that have led to proof of concept studies on new therapeutic approaches. The three selected topics include genetics, epigenetics and non-coding RNA. This new information represents progress in the integration of molecular mechanisms that to identify more effective ways to target lung cancer. |
format | Online Article Text |
id | pubmed-3492398 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | The Korean Academy of Tuberculosis and Respiratory Diseases |
record_format | MEDLINE/PubMed |
spelling | pubmed-34923982012-11-19 Year-in-Review of Lung Cancer Son, Ji Woong Tuberc Respir Dis (Seoul) Review In the last several years, we have made slow but steady progress in understanding molecular biology of lung cancer. This review is focused on advances in understanding the biology of lung cancer that have led to proof of concept studies on new therapeutic approaches. The three selected topics include genetics, epigenetics and non-coding RNA. This new information represents progress in the integration of molecular mechanisms that to identify more effective ways to target lung cancer. The Korean Academy of Tuberculosis and Respiratory Diseases 2012-09 2012-09-28 /pmc/articles/PMC3492398/ /pubmed/23166546 http://dx.doi.org/10.4046/trd.2012.73.3.137 Text en Copyright©2012. The Korean Academy of Tuberculosis and Respiratory Diseases. All rights reserved. http://creativecommons.org/licenses/by-nc/3.0 It is identical to the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) |
spellingShingle | Review Son, Ji Woong Year-in-Review of Lung Cancer |
title | Year-in-Review of Lung Cancer |
title_full | Year-in-Review of Lung Cancer |
title_fullStr | Year-in-Review of Lung Cancer |
title_full_unstemmed | Year-in-Review of Lung Cancer |
title_short | Year-in-Review of Lung Cancer |
title_sort | year-in-review of lung cancer |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3492398/ https://www.ncbi.nlm.nih.gov/pubmed/23166546 http://dx.doi.org/10.4046/trd.2012.73.3.137 |
work_keys_str_mv | AT sonjiwoong yearinreviewoflungcancer |